Cyclin A and Head and Neck Cancer
Author Information
Author(s): Lotayef M, Wilson G D, Daley F M, Awwad H K, Shouman T
Primary Institution: Gray Laboratory Cancer Research Trust, Mount Vernon Hospital, Northwood, Middlesex, UK
Hypothesis
Is aberrant expression of cyclin A prevalent in head and neck squamous cell carcinomas?
Conclusion
Cyclin A may be a more informative marker for cell proliferation than Ki-67, but its aberrant expression in many cases suggests caution in its interpretation.
Supporting Evidence
- The study found a significant correlation between cyclin A expression and known proliferation markers.
- Median labeling indices for IdUrd, cyclin A, and Ki-67 were reported as 10.7%, 17.1%, and 30.8%, respectively.
- Over one third of cases showed aberrant expression of cyclin A.
Takeaway
The study looked at a protein called cyclin A in cancer cells from the head and neck and found it can be helpful for understanding how fast the cells are growing, but sometimes it can be misleading.
Methodology
The study analyzed cyclin A expression in 65 head and neck squamous cell carcinoma samples and compared it with IdUrd and Ki-67 markers.
Limitations
The variability in cyclin A expression and its unexpected relationships with other markers may complicate its use as a proliferation marker.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website